Cochrane Stella A, Arts Josje H E, Ehnes Colin, Hindle Stuart, Hollnagel Heli M, Poole Alan, Suto Hidenori, Kimber Ian
Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire, Mk44 1LQ, UK.
AkzoNobel NV, Arnhem, the Netherlands.
Toxicology. 2015 Jul 3;333:179-194. doi: 10.1016/j.tox.2015.04.010. Epub 2015 May 8.
There is a continuing interest in determining whether it is possible to identify thresholds for chemical allergy. Here allergic sensitisation of the respiratory tract by chemicals is considered in this context. This is an important occupational health problem, being associated with rhinitis and asthma, and in addition provides toxicologists and risk assessors with a number of challenges. In common with all forms of allergic disease chemical respiratory allergy develops in two phases. In the first (induction) phase exposure to a chemical allergen (by an appropriate route of exposure) causes immunological priming and sensitisation of the respiratory tract. The second (elicitation) phase is triggered if a sensitised subject is exposed subsequently to the same chemical allergen via inhalation. A secondary immune response will be provoked in the respiratory tract resulting in inflammation and the signs and symptoms of a respiratory hypersensitivity reaction. In this article attention has focused on the identification of threshold values during the acquisition of sensitisation. Current mechanistic understanding of allergy is such that it can be assumed that the development of sensitisation (and also the elicitation of an allergic reaction) is a threshold phenomenon; there will be levels of exposure below which sensitisation will not be acquired. That is, all immune responses, including allergic sensitisation, have threshold requirement for the availability of antigen/allergen, below which a response will fail to develop. The issue addressed here is whether there are methods available or clinical/epidemiological data that permit the identification of such thresholds. This document reviews briefly relevant human studies of occupational asthma, and experimental models that have been developed (or are being developed) for the identification and characterisation of chemical respiratory allergens. The main conclusion drawn is that although there is evidence that the acquisition of sensitisation to chemical respiratory allergens is a dose-related phenomenon, and that thresholds exist, it is frequently difficult to define accurate numerical values for threshold exposure levels. Nevertheless, based on occupational exposure data it may sometimes be possible to derive levels of exposure in the workplace, which are safe. An additional observation is the lack currently of suitable experimental methods for both routine hazard characterisation and the measurement of thresholds, and that such methods are still some way off. Given the current trajectory of toxicology, and the move towards the use of non-animal in vitro and/or in silico) methods, there is a need to consider the development of alternative approaches for the identification and characterisation of respiratory sensitisation hazards, and for risk assessment.
人们一直对确定是否有可能识别化学过敏阈值感兴趣。在此背景下,本文考虑了化学物质对呼吸道的过敏致敏作用。这是一个重要的职业健康问题,与鼻炎和哮喘相关,此外还给毒理学家和风险评估人员带来了诸多挑战。与所有形式的过敏性疾病一样,化学性呼吸道过敏分两个阶段发展。在第一阶段(诱导阶段),接触化学过敏原(通过适当的接触途径)会引起呼吸道的免疫启动和致敏。如果致敏个体随后通过吸入再次接触相同的化学过敏原,就会引发第二阶段(激发阶段)。呼吸道会引发二次免疫反应,导致炎症以及呼吸道过敏反应的体征和症状。在本文中,重点关注的是致敏过程中阈值的识别。目前对过敏的机制理解是,致敏的发展(以及过敏反应的激发)可以被认为是一种阈值现象;存在一些暴露水平,低于这些水平就不会发生致敏。也就是说,所有免疫反应,包括过敏致敏,对抗原/过敏原的可用性都有阈值要求,低于这个阈值反应就不会发生。这里要解决的问题是是否有可用的方法或临床/流行病学数据能够识别这样的阈值。本文简要回顾了职业性哮喘的相关人体研究,以及为识别和表征化学性呼吸道过敏原而开发(或正在开发)的实验模型。得出的主要结论是,虽然有证据表明对化学性呼吸道过敏原的致敏是一种剂量相关现象,并且存在阈值,但通常很难确定阈值暴露水平的准确数值。然而,根据职业暴露数据,有时可能能够得出工作场所的安全暴露水平。另一个观察结果是,目前缺乏适用于常规危害表征和阈值测量的实验方法,而且距离开发出这样的方法还有很长的路要走。鉴于毒理学的当前发展轨迹以及向使用非动物体外和/或计算机模拟方法的转变,有必要考虑开发替代方法来识别和表征呼吸道致敏危害以及进行风险评估。